Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 15 and 30 years
- People who meet a specific set of clinical criteria (called CAARMS criteria) for an "at-risk mental state," meaning they have mild to moderate early warning signs that may or may not develop into a more serious condition — there are two levels: Stage Ia (mild or vague symptoms and mild difficulties with daily functioning) and Stage Ib (moderate symptoms that are not yet at a level requiring intervention, and moderate difficulties with daily functioning)
- People who have recently experienced their first episode of psychotic symptoms, as identified using standard diagnostic guidelines (DSM-5)
- People who meet the standard diagnostic criteria (DSM-5) for a depressive disorder
- People who meet the standard diagnostic criteria (DSM-5) for autism spectrum disorder
- Healthy volunteers from the general public who do not have any of the conditions listed above
Who may not be able to join:
- People who are considered to be at risk of suicide
- People with serious or unstable physical health or neurological conditions
- People who have epilepsy
- People who have had a significant head injury
- People whose assessed IQ is below 70
- Healthy volunteers who have a family history of psychosis
- People who have been diagnosed with bipolar disorder
- People who have been diagnosed with obsessive-compulsive disorder
- People with a substance use disorder — note that cannabis use of up to 5 joints per day may be tolerated (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Anton Iftimovici, MD, PhD, GHU Paris Psychiatrie et Neurosciences
Phone: 0033(0)145658179
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Occurrence of EEG microstates; Coverage of EEG microstates; Mean duration of EEG microstates
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.